In this project, an Artificial Intelligence-based toolkit will be developed, validated and scaled up for the automatic analysis of the commonly used biomarker Ki67 in cancer biopsies, first in breast cancer tissue and then in other tumors. More information: https://www.wskmedical.org/ ERDF- EUR 203 276